Yoshio Nagai

7PUBLICATIONS
1CO-AUTHORS
Pacific Peoples mothers and babies health and wellbeingPsychosocial aspects of childbirth and perinatal mental healthFood properties (incl. characteristics and health benefits)Clinical pharmacy and pharmacy practiceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 25, 2024
Correction: Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in Japan.

Ayaka Takemoto, Yoshio Nagai, Shin Kawanabe

|Oct 02, 2023
Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in Japan.

Ayaka Takemoto, Yoshio Nagai, Shin Kawanabe

|Jul 22, 2022
Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study.

Yoshiaki Hishida, Yoshio Nagai, Hidekazu Tsukiyama

|Oct 30, 2020
Effect of Eating Glutinous Brown Rice Twice a Day for 6 Weeks on Serum 1,5-Anhydroglucitol in Japanese Subjects without Diabetes.

Taiga Nakayama, Yoshio Nagai, Yuka Yasunaka

|Sep 19, 2017
Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4-week, randomized, open-label, treat-to-target study.

Yoshio Nagai, Ami Nishine, Eriko Hashimoto

|Aug 04, 2017
Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes.

Akio Ohta, Hiroyuki Kato, Satoshi Ishii

Pageof 2

Frequent Collaborators

1 joint publications

Taiga Nakayama